|Oregon Health & Science University School of Medicine|
|City: Portland||State: OR|
Summary:Overall, OHSU presents a strong policy still in need of certain improvements. The gifts, consulting, disclosure and scholarships/trainee funds are model policies. However, the industry sales representative policy allows for representatives to interact with faculty without an appointment and in select patient care areas. Oversight is designated and sanctions are referenced in the policy.
Demographics:Medical students at OHSU complete the majority of their training at either OHSU hospital or the VA hospital. A significant proportion of training does occur at community sites throughout Portland including: Providence Portland Medical Center, Legacy Emmanuel Hospital, Good Samaritan Hospital and Providence St. Vincent's Hospital. In addition, students train at various community hospitals and clinics throughout the states. Rough percentages of clinical training spent at these sites were not available.
Updates:This institution submitted revised policies for review for the 2012-3 Scorecard, their grade remains a B.
This institution's evaluation was last updated: 4/9/2013.
|Gifts & Meals||Although gifts and on-site meals are prohibited in the policy, and the policy score is a "3," the prohibition is restricted to members who are in a "Position of Authority." This definition should be explicity defined to include all members of the University (faculty, staff, students, etc.)|
|Consulting relationships||The policy requires institutional review and approval prior to engaging in a consulting relationship. Consulting relationships are also required to be described in a formal contract.|
|Industry-funded speaking relationships||While there is no policy mandating disclosure of financial conflicts of interests to either the public or patients, the institute requires annual disclosure of significant financial interests.|
|Disclosure||Annual conflict of interest disclosure is required for clinicians and reviewers may require management of the conflict of interest, including the clinician's disclosure of financial ties to his or her patients.|
|Pharmaceutical samples||Although the policy explicitly prohibits the receipt and acceptance of samples by physicians from a pharmaceutical sales representative, samples are not prohibited and dispensement is designated through the pharmacy.|
|Purchasing & Formularies||Committee members are required to annually disclose their financial conflicts of interest. However, the financial conflict of interest management team determines recusal from all committee decisions.|
|Industry Sales Representatives||The policy enables industry sales representatives who lack an appointment to still enter the medical center, including select patient care areas, only after obtaining a dated visitor identification badge and after signing the university's statement of confidentiality. This policy does not limit industry sales representatives' interaction with faculty.|
|On-campus Education||The policy cites adherence to ACCME standards for all on-site education activities. The policy could be strengthened if it clearly states that all contributions be made to a central fund and are independent of industry control.|
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||The policy prohibits the receipt of payment for attendance at off-site lectures and meetings. The policy does not require institutional approval for all travel support.|
|Industry Support for Scholarships & Funds for Trainees||The policy prohibits industry from designating the individual recipient of the funds.|
|Medical school curriculum||Coursework on pharmaceutical marketing and impact on the medical profession occurs in the second year. The goals of the course are to familiarize students with industry marketing strategies and prepare them for interaction with sales representatives.|
|Do the policies specify an oversight mechanism?||The Integrity Office is noted as responsible for implementation and compliance.|
|Are there explicit sanctions for noncompliance?||Sanctions for noncompliance are noted in the policy.|
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|